Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: sandbag who wrote (334)	6/8/1998 8:03:00 PM
From: BARRY ALLEN	Respond to of 4891

I thought I might add that among these 43 study patients are probably druggies, prostitutes, etc. and thereby poor compliers to the treatment regimen. Some probably got the treatment and disappeared for a few months until they were feeling lousy again. With these type of patients the results are better than remarkable! Can you imagine the results on a normal complying patient? Btw, I assume the placebo patients are all DEAD!

To: sandbag who wrote (334)	6/9/1998 8:56:00 AM
From: paper man	Respond to of 4891

Sandbag... Dont worry, you are not confused. You are right. The article, as negative as it was, was not presented clearly. You have made several very important points. All the placebos could have left... all 43 patients could have been advanced stage ( which any treatment success may be difficult in adavanced stage), and any deaths could have been from complications other than viral load. Sandbag... very good points!! It seems that the article had too many negative comments or should we say a servere shortage of solid posititve comments! It seems that every time AVR gets a chance to speak, it is very unclear and is not definitive verbage. Dr. Fraser sounds like some old fart that cant wait to get to lunch for another martini. Havent heard a medical professor use the word " cheap " in a long time. Affordable....... would have left a much better taste in my mouth. Although, he made it clear that the FDA seems not to have interest in it, and maybe because it is " cheap " Like Mr. Bildman said, a third independent party will be needed. good luck, and thank you Mr. Allen for more science!